New White Paper - Read AAM Report on Drug Shortages

Keren Haruvi (Vice Chair)

AAM Board Vice Chair
President of Sandoz US and Head of North America, Sandoz Inc.
Keren Haruvi, President, Sandoz US, Head of North America
Keren Haruvi (Vice Chair)
Sandoz Inc.

Keren Haruvi is AAM Board Vice Chair and President of Sandoz US and Head of North America. In her role at Sandoz, she leads Sandoz’s largest commercial and country organization – the United States – which is responsible for over 35% of Sandoz global revenue. She also oversees Sandoz commercial operations in Canada. In addition to serving on the Novartis Country Leadership Team, Keren is a member of the Global Sandoz Executive Committee.

Prior to joining Sandoz, Keren served as Global Head of M&A at Novartis International AG. Her early career began at Teva Pharmaceutical Industries where she steadily advanced in leadership roles to Senior VP, Global Business Development and Alliance Management. 

Keren is a value creator in the biopharmaceutical space. She brings 17 years of experience in the pharmaceutical industry marked by success leading major M&A deals, enterprise innovations and complex market strategies for large-scale, sustainable growth. 

Keren holds an MBA in Finance from Bar Ilan University and Bachelor’s degrees in Economics and Chemistry from Tel Aviv University. 

Latest Tweets

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.